Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma

被引:55
作者
Begum, Asma [1 ,2 ,3 ,5 ]
Imoto, Issei [1 ,2 ,4 ]
Kozaki, Ken-ichi [1 ,2 ,4 ]
Tsuda, Hitoshi [4 ,6 ]
Suzuki, Emina [1 ,2 ]
Amagasa, Teruo [3 ]
Inazawa, Johji [1 ,2 ,4 ,5 ]
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Grad Sch, Dept Maxillofacial Surg, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Dept Genome Med, Tokyo, Japan
[5] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo, Japan
[6] Natl Def Med Coll, Dept Basic Pathol, Saitama, Japan
关键词
COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN HOMOLOG; CANCER; KINASE; ONCOGENE; SURVIVAL; OVARIAN; OVEREXPRESSION; EXPRESSION; AMPLICON;
D O I
10.1111/j.1349-7006.2009.01252.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Amplification of chromosomal DNA is thought to be one of the mechanisms activating cancer-related genes in tumors. To identify the most likely target for amplification in the region 19q13.12-q13.2, detected previously in SKN-3 cells by a genome-wide screening of DNA copy-number aberrations in a panel of oral squamous-cell carcinoma (OSCC) cell lines, we determined the extent of the amplicon, analyzed a panel of cell lines for the expression of candidate genes within the amplicon, and then evaluated growth-suppressive effects by knocking down genes of interest. Reported information about the function and/or expression of each gene, remarkable overexpression in SKN-3 cells and relatively frequent overexpression in additional OSCC lines compared with an immortalized normal oral epithelial cell line, and expression level-dependent proliferation-promoting activity led us to conclude that the p21-activated kinase 4 (PAK4) gene was the most likely target. An immunohistochemical analysis of primary tumors from 105 cases of head and neck SCC including 50 cases of OSCC demonstrated the overexpression of PAK4 to be significantly associated with a poorer prognosis. These findings reveal that the PAK4 overexpression through amplification or other mechanisms promotes the proliferation and/or survival of OSCC cells, and that PAK4 might be a good diagnostic and/or therapeutic target. (Cancer Sci 2009; 100: 1908-1916).
引用
收藏
页码:1908 / 1916
页数:9
相关论文
共 32 条
[1]
PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia [J].
Abo, A ;
Qu, J ;
Cammarano, MS ;
Dan, CT ;
Fritsch, A ;
Baud, V ;
Belisle, B ;
Minden, A .
EMBO JOURNAL, 1998, 17 (22) :6527-6540
[2]
MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS [J].
BELLACOSA, A ;
DEFEO, D ;
GODWIN, AK ;
BELL, DW ;
CHENG, JQ ;
ALTOMARE, DA ;
WAN, MH ;
DUBEAU, L ;
SCAMBIA, G ;
MASCIULLO, V ;
FERRANDINA, G ;
PANICI, PB ;
MANCUSO, S ;
NERI, G ;
TESTA, JR .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (04) :280-285
[3]
Disease mechanism and biomarkers of oral squamous cell carcinoma [J].
Brinkman, Brigitta M. N. ;
Wong, David T. W. .
CURRENT OPINION IN ONCOLOGY, 2006, 18 (03) :228-233
[4]
Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines [J].
Callow, MG ;
Clairvoyant, F ;
Zhu, S ;
Schryver, B ;
Whyte, DB ;
Bischoff, JR ;
Jallal, B ;
Smeal, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :550-558
[5]
Pak4 induces premature senescence via a pathway requiring p16INK4/P19ARF and mitogen-activated protein kinase signaling [J].
Cammarano, MS ;
Nekrasova, T ;
Noel, B ;
Minden, A .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) :9532-9542
[6]
AKT2, A PUTATIVE ONCOGENE ENCODING A MEMBER OF A SUBFAMILY OF PROTEIN-SERINE THREONINE KINASES, IS AMPLIFIED IN HUMAN OVARIAN CARCINOMAS [J].
CHENG, JQ ;
GODWIN, AK ;
BELLACOSA, A ;
TAGUCHI, T ;
FRANKE, TF ;
HAMILTON, TC ;
TSICHLIS, PN ;
TESTA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9267-9271
[7]
The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma [J].
Deng, Xiaobing ;
Ewton, Daina Z. ;
Li, Sheena ;
Naqvi, Asghar ;
Friedman, Eileen .
CANCER RESEARCH, 2006, 66 (08) :4149-4158
[8]
UnPAKing the class differences among p21-activated kinases [J].
Eswaran, Jeyanthy ;
Soundararajan, Meera ;
Kumar, Rakesh ;
Knapp, Stefan .
TRENDS IN BIOCHEMICAL SCIENCES, 2008, 33 (08) :394-403
[9]
Targeting group II PAKs in cancer and metastasis [J].
Eswaran, Jeyanthy ;
Soundararajan, Meera ;
Knapp, Stefan .
CANCER AND METASTASIS REVIEWS, 2009, 28 (1-2) :209-217
[10]
The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis [J].
Gnesutta, N ;
Qu, J ;
Minden, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :14414-14419